{"id":70699,"date":"2026-05-12T09:19:23","date_gmt":"2026-05-12T09:19:23","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70699"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"selank","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/selank\/","title":{"rendered":"Selank"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le Selank ?<\/h3>\n<p style=\"margin: 0;\"><strong>Selank<\/strong> is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">129954-34-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">751.88 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH<sub>2<\/sub> (TKPRPGP-NH<sub>2<\/sub>, 7 acides amin\u00e9s ; analogue de la tuftsine amid\u00e9 en C-terminal)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (blanche \u00e0 blanc cass\u00e9)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, \u00e0 utiliser dans ~30 jours. Prot\u00e9ger de la lumi\u00e8re. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que le Selank ?<\/h2>\n<p><strong>Selank<\/strong> is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a>. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank&#8217;s well-characterised sequence is TKPRPGP-NH<sub>2<\/sub>, poids mol\u00e9culaire 751,88 Da, formule empirique C<sub>33<\/sub>H<sub>57<\/sub>N<sub>11<\/sub>O<sub>9<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a> page produit. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Voies GABAergiques, s\u00e9rotoninergiques et BDNF<\/h2>\n<p>What makes Selank distinctive among anxiolytic compounds is its <strong>profil de neuromodulation multipathway<\/strong> sans liaison directe des r\u00e9cepteurs au site benzodiaz\u00e9pine du GABA<sub>A<\/sub> benzodiazepine site \u2014 each contributing to the observed anxiolytic and nootropic phenotype in published studies:<\/p>\n<ul>\n<li><strong>Modulation GABAergique sans liaison au site benzodiaz\u00e9pine<\/strong> \u2014 Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank&#8217;s pharmacology.<\/li>\n<li><strong>Signalisation s\u00e9rotoninergique et enk\u00e9phalinergique<\/strong> \u2014 Published studies has documented increased serotonin metabolism (5-HIAA \/ 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.<\/li>\n<li><strong>Expression du BDNF et neuroplasticit\u00e9<\/strong> \u2014 Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank&#8217;s nootropic profile \u2014 improved memory consolidation and learning performance in rodent maze tasks.<\/li>\n<\/ul>\n<p>Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Selank is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Pharmacologie anxiolytique<\/strong> \u2014 tests du labyrinthe en croix sur\u00e9lev\u00e9, champ ouvert et interaction sociale dans des mod\u00e8les de rongeurs d'anxi\u00e9t\u00e9 g\u00e9n\u00e9ralis\u00e9e ; bras comparatifs contre les benzodiaz\u00e9pines (diaz\u00e9pam) et les ISRS (Kozlovskaya et al., Eksp Klin Farmakol ; Inozemtsev et al., Bull Exp Biol Med)<\/li>\n<li><strong>Stress resilience and HPA-axis studies<\/strong> \u2014 mod\u00e8les de stress chronique l\u00e9ger, stress de contention et impuissance apprise ; dynamique du cortisol et de l'ACTH<\/li>\n<li><strong>BDNF and neuroplasticity studies<\/strong> \u2014 expression du BDNF dans l'hippocampe et le cortex pr\u00e9frontal, morphologie des \u00e9pines dendritiques, \u00e9lectrophysiologie de la potentialisation \u00e0 long terme<\/li>\n<li><strong>Cognitive and memory studies<\/strong> \u2014 labyrinthe aquatique de Morris, reconnaissance de nouveaux objets, \u00e9vitement passif ; effets nootropes ind\u00e9pendants de l'anxiolyse<\/li>\n<li><strong>Immunomodulation<\/strong> \u2014 Selank inherits tuftsin&#8217;s immunomodulatory activity, with documented effects on cytokine balance (TNF-\u03b1, IL-6, IFN-\u03b3) and macrophage function in published studies<\/li>\n<li><strong>Comparative studies vs benzodiazepines<\/strong> \u2014 comparaison directe avec le diaz\u00e9pam, l'alprazolam et le ph\u00e9naz\u00e9pam sur l'efficacit\u00e9 anxiolytique, le potentiel de d\u00e9pendance et le rebond ; le profil de sevrage propre du Selank est l'une des d\u00e9couvertes les plus cit\u00e9es dans la litt\u00e9rature russe<\/li>\n<li><strong>Sister-peptide studies<\/strong> \u2014 \u00e9valuation comparative contre <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a> (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.<\/li>\n<\/ul>\n<p>For broader context on small-peptide neuromodulation and nootropic studies, see <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a> comme le comparateur nootropique canonique d\u00e9velopp\u00e9 en Russie, <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> for the parallel small-peptide healing-compound. Browse the full <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a> pour les compos\u00e9s associ\u00e9s. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, intranasal-vehicle formulation studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols. <\/p>\n<h2>Comparaison \u2014 Selank vs Semax<\/h2>\n<p>Selank et <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a> are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic\/neuroprotective. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Semax<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longueur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 acides amin\u00e9s (heptapeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 acides amin\u00e9s (heptapeptide)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peptide parent<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tuftsin (TKPR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fragment ACTH(4-10)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>M\u00e9canisme principal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Modulation GABA, BDNF, enk\u00e9phaline<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BDNF, r\u00e9cepteurs m\u00e9lanocortines, dopamine<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anxiolytique, r\u00e9silience au stress<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootrope, neuroprotecteur, concentration<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 mcg\/jour<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">200\u20131 000 mcg\/jour<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Utilisation clinique en Russie<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anxiolytique approuv\u00e9 (intranasal)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nootrope approuv\u00e9 \/ r\u00e9cup\u00e9ration post-AVC (intranasal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stacking in studies<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fr\u00e9quemment combin\u00e9 avec Semax pour un effet anxiolytique+nootropique compl\u00e9mentaire<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fr\u00e9quemment combin\u00e9 avec Selank<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because the two peptides act on complementary axes \u2014 Selank on GABA\/anxiolytic, Semax on melanocortin\/dopaminergic\/nootropic \u2014 they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> Conservez les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans leur emballage d'origine pour un stock de travail \u00e0 court terme. Pour un stockage \u00e0 long terme non ouvert, congelez \u00e0 \u221220 \u00b0C. Le Selank lyophilis\u00e9 est stable sous r\u00e9frig\u00e9ration jusqu'\u00e0 24 mois et \u00e0 \u221220 \u00b0C jusqu'\u00e0 36 mois. \u00c9vitez les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation de la poudre lyophilis\u00e9e. <strong>Proc\u00e9dure de reconstitution :<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 1.0\u00a0mL of bacteriostatic water yields a 5\u00a0mg\/mL working concentration; 0.1\u00a0mL delivers a 500\u00a0mcg dose. Swirl gently \u2014 do <strong>re\u00e7oit pas<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>Apr\u00e8s reconstitution :<\/strong> conservez au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C et utilisez dans les 30 jours pour une stabilit\u00e9 optimale. Ne congelez pas la solution reconstitu\u00e9e \u2014 les cycles de gel-d\u00e9gel d\u00e9gradent l'int\u00e9grit\u00e9 du peptide. Jetez tout flacon pr\u00e9sentant de la turbidit\u00e9, un pr\u00e9cipit\u00e9 ou une d\u00e9coloration. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is Selank used for in studies?<\/h3>\n<p>Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is <strong>re\u00e7oit pas<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>En quoi le Selank est-il diff\u00e9rent du Semax ?<\/h3>\n<p>Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways \u2014 canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation \u2014 canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping. <\/p>\n<h3>What is the typical Selank dose?<\/h3>\n<p>Published Russian protocols typically use 300\u2013900\u00a0mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5\u00a0mg vial reconstituted with 1.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 0.1\u00a0mL equals 500\u00a0mcg, a typical single-dose studies aliquot. <\/p>\n<h3>Non. Le Selank n'est approuv\u00e9 ni par la FDA, ni par l'EMA, ni par la MHRA, ni par aucun grand r\u00e9gulateur occidental. Il est approuv\u00e9 en Russie comme anxiolytique sur ordonnance sous le nom de marque Selank (spray intranasal, ZAO Pharm-Sintez). Tout Selank vendu par des fournisseurs r\u00e9serv\u00e9s \u00e0 la recherche en dehors de la Russie est destin\u00e9 \u00e0 des investigations en laboratoire et ne doit pas \u00eatre administr\u00e9 \u00e0 des humains.<\/h3>\n<p>No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez). <\/p>\n<h3>Comment doit \u00eatre stock\u00e9 le Selank ?<\/h3>\n<p>Flacons lyophilis\u00e9s : conserv\u00e9s au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C pour les stocks de travail \u00e0 court terme, ou \u00e0 \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Solution reconstitu\u00e9e : conserv\u00e9e au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e \u2014 les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation d\u00e9gradent le peptide. Prot\u00e9ger de la lumi\u00e8re directe en permanence. <\/p>\n<h3>Comment reconstituer le Selank ?<\/h3>\n<p>Suivez la proc\u00e9dure de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi du flacon (pas directement sur la poudre lyophilis\u00e9e), agitez doucement et laissez reposer 2 \u00e0 5 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> agitez le flacon. Une solution correctement reconstitu\u00e9e est claire et incolore. Pour un flacon de 5 mg + 1,0 mL de diluant, la concentration de travail est de 5 mg\/mL. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase carries Selank in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Selank be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models. <\/p>\n<h3>Can Selank and Semax be stacked in studies?<\/h3>\n<p>Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA\/enkephalin\/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin\/dopaminergic\/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress. <\/p>\n<h3>Does Selank cause side reported effects?<\/h3>\n<p>Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation \u2014 in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review. <\/p>\n<h3>Quelle est la demi-vie du Selank ?<\/h3>\n<p>In preclinical studies, Selank has an estimated plasma half-life of approximately 15\u201330 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance. <\/p>\n<h3>How long does Selank take to show effects in preclinical studies?<\/h3>\n<p>Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30\u201360 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7\u201314 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models. <\/p>\n<h3>Puis-je commander du Selank pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die le Selank dans le monde entier depuis notre r\u00e9seau d\u00e9di\u00e9 \u00e0 l'exp\u00e9dition de peptides. Les commandes contenant uniquement des peptides sont \u00e9ligibles \u00e0 notre service d'exp\u00e9dition d\u00e9di\u00e9. Toutes les commandes sont exp\u00e9di\u00e9es dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet et sont couvertes par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\">Politique de R\u00e9exp\u00e9ditions Garanties<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies<\/h2>\n<ul>\n<li><a href=\"\/fr\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Sister heptapeptide from the same Russian clinical \u2014 nootropic and neuroprotective studies<\/li>\n<li><a href=\"\/fr\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/fr\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<li><a href=\"\/fr\/kpv-lysine-proline-valine\/\"><strong>KPV<\/strong><\/a> \u2014 Small immunomodulatory tripeptide \u2014 inflammation and barrier studies<\/li>\n<li><a href=\"\/fr\/adamax\/\"><strong>Adamax<\/strong><\/a> \u2014 Heptapeptide nootropic compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore small-peptide nootropic studies<\/strong><\/p>\n<p style=\"margin: 0;\">Parcourez toute la <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\"><strong>catalogue de peptides<\/strong><\/a>, avec des compos\u00e9s apparent\u00e9s incluant <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a> for melanocortin-axis nootropic studies, <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> for pineal-peptide longevity studies, and <a href=\"https:\/\/medsbase.com\/fr\/adamax\/\">Adamax<\/a> for sister heptapeptide cognitive studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Anxiolytique sans s\u00e9dation<br \/>\n\u2705 Modulation multi-voies GABA \/ BDNF \/ enk\u00e9phaline<br \/>\n\u2705 Stress-resilience compound<br \/>\n\u2705 Peptide biodisponible par voie intranasale<br \/>\n\u2705 Profil de sevrage propre compar\u00e9 aux benzodiaz\u00e9pines<\/p>\n<p><strong>Selank<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70977,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,6273],"class_list":["post-70699","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-selank","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/70699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=70699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70977"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=70699"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=70699"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=70699"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=70699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}